Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00479492 · ClinicalTrials.gov registry record · Phase 2
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 94
- Enrollment target
NCT00479492 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 94 participants.
The verdict
NCT00479492, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.
Interventions
- DRUG placebo
- DRUG CP-866,087
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00479492
The ClinicalTrials.gov registry entry for NCT00479492 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00479492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00479492 about?
NCT00479492 is a clinical study titled "Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers". The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.
What is the current status of trial NCT00479492?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 94 participants. The study started on 2007-06. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00479492?
The interventions under investigation include: placebo (DRUG), CP-866,087 (DRUG).
Who is sponsoring clinical trial NCT00479492?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.